The prevalence of nonmalignant gastrointestinal disease in patients with iron deficiency anemia: a systematic review and meta-analysis.
메타분석
1/5 보강
PICO 자동 추출 (휴리스틱, conf 3/4)
유사 논문P · Population 대상 환자/모집단
9807 patients with IDA.
I · Intervention 중재 / 시술
endoscopic investigation
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSION] The estimated prevalence of individual malignant and nonmalignant gastrointestinal disease will serve as a guide in the context of clinical decision making before endoscopy in patients with IDA. Further population-based studies are needed, particularly among relevant subgroups.
[OBJECTIVE] Gastrointestinal pathology is a major cause of iron deficiency anemia (IDA).
- 연구 설계 systematic review
APA
De Silva R, Thomas JP, et al. (2026). The prevalence of nonmalignant gastrointestinal disease in patients with iron deficiency anemia: a systematic review and meta-analysis.. European journal of gastroenterology & hepatology. https://doi.org/10.1097/MEG.0000000000003160
MLA
De Silva R, et al.. "The prevalence of nonmalignant gastrointestinal disease in patients with iron deficiency anemia: a systematic review and meta-analysis.." European journal of gastroenterology & hepatology, 2026.
PMID
41784434 ↗
Abstract 한글 요약
[OBJECTIVE] Gastrointestinal pathology is a major cause of iron deficiency anemia (IDA). While previous studies have focused on establishing the prevalence of malignant gastrointestinal disease, the prevalence of nonmalignant gastrointestinal disease in patients with IDA has not been analyzed systematically. We performed a systematic review and meta-analysis to determine the prevalence of normal findings, individual nonmalignant findings, and malignancy in patients with IDA.
[METHODS] We searched Medline, Embase, and Scopus from inception for observational studies that reported the prevalence of individual upper and lower gastrointestinal pathologies among adults (≥18 years) with confirmed IDA who underwent endoscopic investigation. We also sought to establish the prevalence of normal endoscopic findings within the IDA population as well as the prevalence of nonmalignant and malignant gastrointestinal pathology amongst clinically relevant subgroups. Results were synthesized using a random effects meta-analysis.
[RESULTS] A total of 8563 citations were screened, and 39 articles were included from four continents, comprising 9807 patients with IDA. Overall, the most prevalent upper gastrointestinal finding was Helicobacter pylori gastritis (27.0%), and the most prevalent lower gastrointestinal finding was hemorrhoids (10.0%). The overall prevalence of upper gastrointestinal malignancy was 5.0%, and the prevalence of colorectal cancer was 8.0%. A total of 52.0% of upper gastrointestinal endoscopies and 66.0% of lower gastrointestinal endoscopies did not detect any abnormalities.
[CONCLUSION] The estimated prevalence of individual malignant and nonmalignant gastrointestinal disease will serve as a guide in the context of clinical decision making before endoscopy in patients with IDA. Further population-based studies are needed, particularly among relevant subgroups.
[METHODS] We searched Medline, Embase, and Scopus from inception for observational studies that reported the prevalence of individual upper and lower gastrointestinal pathologies among adults (≥18 years) with confirmed IDA who underwent endoscopic investigation. We also sought to establish the prevalence of normal endoscopic findings within the IDA population as well as the prevalence of nonmalignant and malignant gastrointestinal pathology amongst clinically relevant subgroups. Results were synthesized using a random effects meta-analysis.
[RESULTS] A total of 8563 citations were screened, and 39 articles were included from four continents, comprising 9807 patients with IDA. Overall, the most prevalent upper gastrointestinal finding was Helicobacter pylori gastritis (27.0%), and the most prevalent lower gastrointestinal finding was hemorrhoids (10.0%). The overall prevalence of upper gastrointestinal malignancy was 5.0%, and the prevalence of colorectal cancer was 8.0%. A total of 52.0% of upper gastrointestinal endoscopies and 66.0% of lower gastrointestinal endoscopies did not detect any abnormalities.
[CONCLUSION] The estimated prevalence of individual malignant and nonmalignant gastrointestinal disease will serve as a guide in the context of clinical decision making before endoscopy in patients with IDA. Further population-based studies are needed, particularly among relevant subgroups.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Prostate Cancer Care for Men with an Intellectual Disability: A Population-based Cohort Study of Symptoms, Diagnosis, Treatment, and Survival.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Association between polygenic risk scores and cardiovascular events in prostate cancer patients receiving androgen deprivation therapy in Han Chinese.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.